Real-World Effectiveness and Safety of Blinatumomab in Adults with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukaemia in Europe: 3-Year Results in Philadelphia Chromosome-Negative Patients and a Subset of Patients with Late First Relapse

被引：2
|
作者：
Thomas, Xavier
Rijneveld, Anita W.
Fracchiolla, Nicola
Salek, Cyril
Spyridonidis, Alexandros
Chiaretti, Sabina
Alam, Naufil
Grueter, Isabella Pezzani
Mohammad, Abeera
Kormany, William
Kreuzbauer, Georg
Rambaldi, Alessandro
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134470
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapse
    Heraudet, Luc
    Galtier, Jean
    Favre, Simon
    Peyraud, Florent
    Cazaubiel, Titouan
    Leroy, Harmony
    Mottal, Nathan
    Gros, Francois-Xavier
    Forcade, Edouard
    Clement, Laurence
    Dumas, Pierre-Yves
    Pigneux, Arnaud
    Leguay, Thibaut
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (03) : 523 - 527
  • [2] Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab
    Short, Nicholas J.
    Macaron, Walid
    Konopleva, Marina
    Ravandi, Farhad
    Jain, Nitin
    Issa, Ghayas C.
    Kadia, Tapan
    Sasaki, Koji
    Kebriaei, Partow
    Yilmaz, Musa
    Thompson, Philip A.
    Takahashi, Koichi
    Abbas, Hussein A.
    Wierda, William G.
    Garris, Rebecca
    Kantarjian, Hagop M.
    Jabbour, Elias
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : E201 - E204
  • [3] Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain
    Boluda, Blanca
    Rodriguez-Veiga, Rebeca
    Martinez-Cuadron, David
    Lorenzo, Ignacio
    Sanz, Jaime
    Regadera, Ana
    Sempere, Amparo
    Senent, Leonor
    Vicente Cervera, Jose
    Solves, Pilar
    Reitan, John
    Gea, Salvador
    Angel Sanz, Miguel
    Montesinos, Pau
    PHARMACOECONOMICS-OPEN, 2019, 3 (02) : 229 - 235
  • [4] Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain
    Blanca Boluda
    Rebeca Rodríguez-Veiga
    David Martínez-Cuadrón
    Ignacio Lorenzo
    Jaime Sanz
    Ana Regadera
    Amparo Sempere
    Leonor Senent
    Jose Vicente Cervera
    Pilar Solves
    John Reitan
    Salvador Gea
    Miguel Angel Sanz
    Pau Montesinos
    PharmacoEconomics - Open, 2019, 3 : 229 - 235
  • [5] A Real-World Evidence on Effectiveness and Safety of Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia
    Zhou, Huifen
    Miao, Miao
    Wu, Xiaoxia
    Yang, Zhen
    Lu, Shenqi
    Zhang, Xinhui
    Yang, Xiaofei
    Chen, Suning
    Wu, Depei
    Gao, Yangyang
    BLOOD, 2023, 142
  • [6] Treatment of Adults with Relapsed/Refractory Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia with Blinatumomab in a Real-World Setting: Results from the Neuf Study
    Boissel, Nicolas
    Ribera, Josep-Maria
    Chiaretti, Sabina
    Rambaldi, Alessandro
    Bassan, Renato
    Papayannidis, Cristina
    Alam, Naufil
    Brescianini, Alessandra
    Pezzani, Isabella
    Kreuzbauer, Georg
    Foa, Robin
    BLOOD, 2019, 134
  • [7] Estimating the relative treatment effect and corresponding cost-effectiveness estimates of inotuzumab ozogamicin versus blinatumomab for adults with Philadelphia chromosome-negative relapsed/refractory B-cell acute lymphoblastic leukaemia in the United Kingdom
    Russell-Smith, T. A.
    Cooper, M.
    van Oostrum, I.
    Welch, V.
    Critchlow, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 186 - 187
  • [8] BUDGET IMPACT ANALYSIS OF BLINATUMOMAB FOR THE TREATMENT OF PEDIATRIC PATIENTS WITH PHILADELPHIA NEGATIVE RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN MEXICO
    Alva, M. E.
    Ortiz, M.
    Flores, B.
    VALUE IN HEALTH, 2018, 21 : S27 - S27
  • [9] BUDGET IMPACT ANALYSIS COMPARING BLINATUMOMAB IN THE TREATMENT OF ADULTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) WITH FLAG-IDA AND HYPER CVAD
    Naranjo, M.
    Alva, M. E.
    Munoz, I
    VALUE IN HEALTH, 2017, 20 (09) : A549 - A549
  • [10] Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
    Bonifacio, Massimiliano
    Papayannidis, Cristina
    Lussana, Federico
    Fracchiolla, Nicola
    Annunziata, Mario
    Sica, Simona
    Delia, Mario
    Foa, Robin
    Pizzolo, Giovanni
    Chiaretti, Sabina
    FRONTIERS IN ONCOLOGY, 2022, 11
12345